Facebook Analyst: Tech Firms Will Have to Invest "Billions" in Security
While some Facebook execs were in Washington, D.C. Wednesday, testifying about Russia-backed ads, CEO Mark Zuckerberg announced blow-out earnings. The company reported ad revenue of over $10 billion and 2.07 billion monthly active users. Daniel Ives, Chief Strategy Officer and Head of Technology Research at GBH Insights, discusses the social media platform's 2018 guidance.
Zuckerberg said 2018 will be a year of "investment." Ives believes this should be used to further expand its ad growth, AR, mobile platforms, video, consumer engagement, and Instagram/Messenger monetization into 2018 and beyond. However, Ives said the platform will need to invest billions in security, which concerns investors. Zuckerberg warns that the company's future profitability will be impacted because of it.
Plus, we can't forget Apple. The tech giant reports earnings after the bell Thursday. Ives says early demand for the iPhone X will continue throughout the year. He says the Street really wants to see guidance for 75-80 million units in the month of December. He believes this will be Apple's biggest super cycle.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
